David E. Cohen - 05 Nov 2025 Form 4 Insider Report for Evommune, Inc.

Reporting relationship: Director
Issuer ticker: EVMN on NYSE
Reported as of: 05 Nov 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 07 Nov 2025, 16:15:18 UTC
Prior SEC filing: 18 Apr 2023
Next SEC filing: 12 Nov 2025
Source filing: View source filing
Reporting owner signature: /s/ Gregory S. Moss, Attorney-in-Fact

Key filing fact

David E. Cohen filed Form 4 for Evommune, Inc. on 07 Nov 2025.

Key facts

This page summarizes David E. Cohen's Form 4 filing for Evommune, Inc..
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 07 Nov 2025, 16:15.

Change

Previous filing in this sequence was filed on 18 Apr 2023.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001347383 Primary reporting owner

Cohen David E

Relationship: Director
Address: C/O EVOMMUNE, INC., 1841 PAGE MILL ROAD, SUITE 100, PALO ALTO
Signature: /s/ Gregory S. Moss, Attorney-in-Fact
Signature date: 07 Nov 2025

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

EVMN transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +37,960
Change %
Price: $0.000000
Shares after: 37,960
Date: 05 Nov 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 37,960
Exercise price: $16.00
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

One third (1/3) of the shares subject to the option award shall vest on November 5, 2026 and the remaining shares subject to the option shall vest in twenty-four (24) equal monthly installments thereafter, subject to the Reporting Person's continuous service through such vesting date.